Based on todays evidence: Injections produce the highest overall weight loss Oral options offer unmatched convenience with strong early results Both are effective for people with obesity or type 2 diabetes For many patients, the choice is not just which is stronger? But its which is easier to stay on long-term? Side Effects: What the Study Found The clinical trial results for GLP-1 treatments show that orforglipron has a similar side-effect pattern to other GLP-1 receptor agonists: most issues are gastrointestinal and mild to moderate
This is counterproductive on multiple levels
I think that whats becoming apparent with the GLP-1s, with respect to medical applications, is theyve got pretty broad reach, he says
Is it inherently the medicine, and is it the dose? More data is on the way to address the question of whether it works
The pocket volumes of inactive (GLP-1RFab7F38), active-like (GLP-1Rpeptide 5), and active (GLP-1RGLP-1Gs) structures were calculated with POVME 35
Lifestyle, exercise, and nutrition support